Dr. Ning Z. Wu, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 998
Licensed in Illinois since 2003, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Duke University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
IL license 036108948 (first issued 2003; not renewed)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Northwestern Medicine Mchenry Mchenry, IL
- Advocate Sherman Hospital Elgin, IL
- Advocate Good Shepherd Hospital Barrington, IL
- St Alexius Medical Center Hoffman Estates, IL
Medical groups
- Comprehensive Urologic Care S C (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 998
- Services billed
- 11,664
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,100 | 40 |
| Bcg live intravesical instillation, 1 mg | 3,900 | 14 |
| Established patient office or other outpatient visit, 30-39 minutes | 677 | 516 |
| Automated urinalysis test | 549 | 383 |
| Established patient office or other outpatient visit, 20-29 minutes | 322 | 252 |
| Ultrasound measurement of bladder capacity after voiding | 202 | 178 |
| Injection, ceftriaxone sodium, per 250 mg | 168 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 164 | 118 |
| Diagnostic exam of bladder and urethra using an endoscope | 152 | 116 |
| Cell examination of specimen, concentration technique | 151 | 117 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Lake Barrington, IL | 981 |
| Finasteride Other prescribers in Lake Barrington, IL | 503 |
| Orgovyx (relugolix) | 211 |
| Dutasteride Other prescribers in Lake Barrington, IL | 119 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Lake Barrington, IL | 113 |
| Xtandi (enzalutamide) | 96 |
| Myrbetriq (mirabegron) Other prescribers in Lake Barrington, IL | 71 |
| Testosterone Cypionate Other prescribers in Lake Barrington, IL | 38 |
| Silodosin Other prescribers in Lake Barrington, IL | 33 |
| Tolterodine Tartrate Er (tolterodine tartrate) Other prescribers in Lake Barrington, IL | 32 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 32 payments worth $1,708 in total to this clinician.
| Procept Biorobotics Corporation | $844 |
|---|---|
| Ferring Pharmaceuticals Inc. | $155 |
| Urogen Pharma, Inc. | $147 |
| Dendreon Pharmaceuticals LLC | $100 |
| Sumitomo Pharma America, Inc. | $76.46 |
| Angiodynamics, Inc. | $74.48 |
| Bayer HealthCare Pharmaceuticals Inc. | $72.29 |
| Astellas Pharma US Inc | $71.33 |
| Food and Beverage | $1,115 |
|---|---|
| Travel and Lodging | $593 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Procept Biorobotics Corporation Jan 30, 2025 | Travel and Lodging AQUABEAM ROBOTIC SYSTEM · Urology · travel to Dallas, TX · in-kind | $267 |
| Procept Biorobotics Corporation Mar 1, 2025 | Travel and Lodging AQUABEAM ROBOTIC SYSTEM · Urology · travel to Barrington, IL | $206 |
| Procept Biorobotics Corporation Feb 28, 2025 | Travel and Lodging AQUABEAM ROBOTIC SYSTEM · Urology · travel to Barrington, IL | $45.54 |
| Procept Biorobotics Corporation Mar 1, 2025 | Travel and Lodging AQUABEAM ROBOTIC SYSTEM · Urology · travel to Barrington, IL | $45.54 |
| Procept Biorobotics Corporation Jan 30, 2025 | Travel and Lodging AQUABEAM ROBOTIC SYSTEM · Urology · travel to Dallas, TX · in-kind | $29.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $81,380 in research payments for these studies, mostly to the institutions running them.
- A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Ca…
AstraZeneca Pharmaceuticals LP - A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Sumitomo Pharma America, Inc. · Completed · NCT05467176 - BlueWind RENOVA iStim™ System for the Treatment of OAB
Bluewind Medical · Completed · NCT03596671 - PINNACLE
Laborie Medical Technologies Corp.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.